Adherium Ltd. (ADR) Price & Analysis

Q: What was Adherium Ltd.’s price range in the past 12 months?

Adherium Ltd. lowest share price was <AU$0.01 and its highest was AU$0.09 in the past 12 months.

Q: What is Adherium Ltd.’s market cap?

Adherium Ltd.’s market cap is AU$15.45M.

Q: When is Adherium Ltd.’s upcoming earnings report date?

Adherium Ltd.’s upcoming earnings report date is Feb 26, 2026 which is in 9 days.

Q: How were Adherium Ltd.’s earnings last quarter?

Adherium Ltd. released its earnings results on Aug 29, 2025. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.009.

Q: Is Adherium Ltd. overvalued?

According to Wall Street analysts Adherium Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Adherium Ltd. pay dividends?

Adherium Ltd. does not currently pay dividends.

Q: What is Adherium Ltd.’s EPS estimate?

Adherium Ltd.’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Adherium Ltd. have?

Adherium Ltd. has 3,090,976,600 shares outstanding.

Q: What happened to Adherium Ltd.’s price movement after its last earnings report?

Adherium Ltd. reported an EPS of -AU$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Adherium Ltd.?

Currently, no hedge funds are holding shares in AU:ADR

Compare

36 Followers

ADR Stock Chart & Stats

AU$0.01

AU$0.00(0.00%)

At close: Jan 09 4:00 PM EST

AU$0.01

AU$0.00(0.00%)

Day’s Range― - ―

52-Week Range<AU$0.01 - AU$0.09

Previous CloseN/A

Volume40.01K

Average Volume (3M)1.17M

Market Cap

AU$15.45M

Enterprise ValueAU$12.71M

Total Cash (Recent Filing)AU$43.26K

Total Debt (Recent Filing)AU$3.12M

Price to Earnings (P/E)―

Beta2.61

Next Earnings

Feb 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding3,090,976,600

10 Day Avg. Volume107,278

30 Day Avg. Volume1,170,790

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)-0.76

Price to Sales (P/S)4.40

P/FCF Ratio-0.36

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Innovative Product OfferingAdherium's focus on smart inhaler technology positions it as a leader in digital health solutions, enhancing medication adherence and treatment outcomes, which is critical in the growing chronic respiratory disease market.

Strategic PartnershipsPartnerships with pharmaceutical companies and healthcare providers enhance Adherium's market reach and integration into treatment regimens, potentially leading to stable revenue streams and growth opportunities.

Healthcare Ecosystem IntegrationBy focusing on improving patient adherence and outcomes, Adherium strengthens its role in the healthcare ecosystem, which can attract increased funding and investment, supporting long-term business sustainability.

Bears Say

Negative Revenue GrowthDeclining revenue growth indicates challenges in market expansion and product adoption, which could hinder long-term profitability and competitive positioning in the medical devices industry.

Financial InstabilityNegative equity and solvency risks highlight financial instability, limiting Adherium's ability to invest in growth initiatives and potentially affecting its long-term viability.

Weak Cash Flow GenerationDeteriorating cash generation capabilities suggest operational inefficiencies and insufficient cash flow to support ongoing operations, posing a risk to Adherium's financial health and sustainability.

Adherium Ltd. News

Adherium relocates Melbourne headquarters and principal office

An announcement from Adherium Ltd. ( ($AU:ADR) ) is now available. Adherium Ltd., a Melbourne-based provider of digital...

7d ago

ADR

K One W One Ceases to Be Substantial Holder in Adherium After Share Dilution

The latest announcement is out from Adherium Ltd. ( ($AU:ADR) ). Adherium Limited has disclosed that K One...

8d ago

ADR

Adherium Cautions Investors on Risks and Uncertainties in New Presentation

The latest update is out from Adherium Ltd. ( ($AU:ADR) ). Adherium Ltd has released an investor presentation...

12d ago

ADR

Adherium Corrects Appendix 4C Financing Disclosures Without Impacting Cash Balance

Adherium Ltd. ( ($AU:ADR) ) has issued an announcement. Adherium Limited has issued a corrected quarterly cash flow...

13d ago

ADR

Adherium Surges in Device Shipments and RPM Revenue After Transformational Year

An update from Adherium Ltd. ( ($AU:ADR) ) is now available. Adherium reported a strong December 2025 quarter,...

18d ago

ADR

Adherium Issues 25.5 Million New Shares with Cleansing Notice to Maintain Trading Flexibility

The latest announcement is out from Adherium Ltd. ( ($AU:ADR) ). Adherium Limited has issued 25,510,000 fully paid...

28d ago

ADR

Adherium Seeks ASX Quotation for 25.5 Million New Shares

Adherium Ltd. ( ($AU:ADR) ) has shared an announcement. Adherium Ltd has applied to the ASX for quotation...

28d ago

ADR

Adherium Director George Baran Boosts Equity Stake Through Note Conversions and Option Exercises

Adherium Ltd. ( ($AU:ADR) ) has shared an update. Adherium Limited has disclosed substantial changes to director George...

1M ago

ADR

Adherium Director George Baran Converts Notes and Expands Equity Stake

The latest update is out from Adherium Ltd. ( ($AU:ADR) ). Adherium director George Baran has significantly increased...

1M ago

ADR

Adherium Issues Over 554 Million New Shares and Lodges Cleansing Notice

Adherium Ltd. ( ($AU:ADR) ) has issued an announcement. Adherium Limited has issued 554,114,211 fully paid ordinary shares...

2M ago

ADR

ADR FAQ

What was Adherium Ltd.’s price range in the past 12 months?

Adherium Ltd. lowest share price was <AU$0.01 and its highest was AU$0.09 in the past 12 months.

What is Adherium Ltd.’s market cap?

Adherium Ltd.’s market cap is AU$15.45M.

When is Adherium Ltd.’s upcoming earnings report date?

Adherium Ltd.’s upcoming earnings report date is Feb 26, 2026 which is in 9 days.

How were Adherium Ltd.’s earnings last quarter?

Adherium Ltd. released its earnings results on Aug 29, 2025. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.009.

Is Adherium Ltd. overvalued?

According to Wall Street analysts Adherium Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Adherium Ltd. pay dividends?

Adherium Ltd. does not currently pay dividends.

What is Adherium Ltd.’s EPS estimate?

Adherium Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Adherium Ltd. have?

Adherium Ltd. has 3,090,976,600 shares outstanding.

What happened to Adherium Ltd.’s price movement after its last earnings report?

Adherium Ltd. reported an EPS of -AU$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Adherium Ltd.?

Currently, no hedge funds are holding shares in AU:ADR

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Adherium Ltd. Stock Smart Score

Neutral

Blogger Sentiment

Bullish

AU:ADR Sentiment 100%
Sector Average ―

Insider Transactions

Bought Shares

Worth AU$20.0K over
the Last 3 Months

Fundamentals

Return on Equity

-1476.79%

Trailing 12-Months

Asset Growth

-64.44%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Adherium Ltd.

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. The company offers Hailie, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around a patient's inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal. The company was incorporated in 2001 and is based in Auckland, New Zealand.